Robert Gut compensation by year
uniQure Summary Compensation Table · all 3 fiscal years held| Component | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
| Salary | $177,751 | $532,816 | $370,454 |
| Bonus | $0 | $0 | $0 |
| Stock awards | $132,123 | $631,842 | $641,408 |
| Option awards | $158,776 | $570,499 | $640,928 |
| Non-equity incentive | $81,768 | $185,951 | $139,186 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $11,750 | $28,346 | $673,199 |
| Total | $562,168 | $1,949,454 | $2,465,175 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: uniQure N.V. DEF 14A filed September 17, 2021, accession 0001104659-21-116939, and prior-year filings.
How this page was built: the uniQure N.V. filed document, accession 0001104659-21-116939. Every figure is read from that document and cited to the page and table it appears in. Filed September 17, 2021.
Equity holdings
unvested awards at FY2020 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 12,380 | $447,289 | — |
| RSU | 11,667 | $421,529 | — |
| PSU | 5,610 | $202,689 | — |
| RSU | 3,431 | $123,962 | — |
| Option | 30,625 | — | $39.97 |
| Option | 9,494 | — | $31.71 |
| Option | 21,719 | — | $51.81 |
| Option | 1,667 | — | $35.40 |
Per the Outstanding Equity Awards at Fiscal Year-End table in uniQure N.V.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
20 Form 4 lines since the FY2020 proxy (filed September 17, 2021)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-06-11 | Sale | 10b5-1 | 2,726 | $27.06 | 32,259 |
| 2026-06-10 | Sale | 10b5-1 | 1,780 | $26.05 | 27,435 |
| 2026-06-10 | Exercise or conversion derivative | 10b5-1 | 2,645 | $0.00 | 0 |
| 2026-06-10 | Exercise or conversion | 10b5-1 | 2,645 | $16.04 | 34,987 |
| 2026-06-10 | Grant or award | 10b5-1 | 7,550 | $0.00 | 34,985 |
| 2026-06-10 | Sale | 10b5-1 | 3,127 | $26.03 | 29,215 |
| 2026-06-10 | Grant or award derivative | 10b5-1 | 13,980 | $0.00 | 13,980 |
| 2026-06-10 | Sale | 10b5-1 | 2,645 | $26.07 | 32,342 |
The 8 most recent of 20 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
uniQure’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Matthew Kapusta | Chief Executive Officer and Executive Director | $4,465,377 |
| Ricardo Dolmetsch | Former Chief Scientific Officer | $3,369,278 |
| Robert Gut · this page | Chief Medical Officer, Executive Director | $2,465,175 |
| Sander van Deventer | Executive Vice President, Product and Research Development | $2,255,486 |
| Alexander Kuta | Senior Vice President | $1,934,911 |
| Christian Klemt | Chief Financial Officer | $1,247,461 |
Board service
uniQure board · FY2021–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $52,500 | $129,273 | $137,857 | $0 | $319,630 |
| FY2024 | $52,500 | $36,926 | $36,918 | $0 | $126,344 |
| FY2023 | $50,267 | $175,566 | $179,130 | — | $404,963 |
| FY2022 | $46,370 | $152,452 | $151,861 | — | $350,682 |
| FY2021 | $46,134 | $88,134 | $79,676 | — | $213,944 |
Each year as the company reported it in uniQure's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: uniQure pays directors a $45,000 cash retainer. As stated in uniQure's FY2025 proxy.
Committees
Research & Development
The full uniQure compensation record
free company briefThis page is one person within uniQure's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the uniQure proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are uniQure's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.